EGFR and neoplasm: The patient developed multiple TKI resistance mechanisms: T790M <i>EGFR</i> resistance mutation, detected only on tumor cell-free DNA, squamous cell transformation and <i>MET</i> amplification, both detected on a tumor re-biopsy.